Bristol Myers Squibb

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Bristol Myers Squibb ( BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. This stock is trading down 0.09% at $34.24 in recent trading after hitting a 52-week high of $34.50 earlier in the day.

Today's Range: $34.21-$34.50

52-Week Range: $24.97-$34.50

Volume: 9.8 million

Three-Month Average Volume: 13.3 million

Bristol Myers Squibb has a market cap of $58.06 billion and an enterprise value of $55.50 billion. The stock trades at a trailing price-to-earnings of 17.67. The stock also trades at a price-to-sales of 2.78 and a price-to-book of 3.50. The current short interest as a percentage of the float for Bristol Myers Squibb is 1.7%.

From a technical standpoint, BMY recently triggered a breakout trade after the stock cleared some past overhead resistance at $33.20 to $33.27 on decent volume. Market players should now stay with a long bias trading plan for BMY as long as the stock doesn't move back below those key breakout levels.

Bristol-Myers was featured recently in " 7 Dividend Stocks Shoveling Cash to Shareholders."

If you liked this article you might like

Biotech Movers: Acceleron, Clovis, Coherus

Biotech Movers: Coherus, XBiotech, Flexion

AbbVie Stock Lower on Humira Patent Ruling

Here's What Blackstone Bought and Sold in the Fourth Quarter

Here's What Blackstone and KKR Are Buying